Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase IIa Study of TAS-205 in Patients With Duchenne Muscular Dystrophy

NCT02752048 is registered in ClinicalTrials.gov with Taiho Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT02752048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02752048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase IIa Study of TAS-205 in Patients With Duchenne Muscular Dystrophy
Lead sponsor
Taiho Pharmaceutical Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2016
Completion date
October 17, 2017
Enrollment
36 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

duchenne muscular dystrophy